The new initiate strives to raise 7.5 billion euros to aid the discovery and development of a coronavirus vaccine More: EU leaders pledge support for global COVID-19 effort Source: News
read moreJohnson & Johnson is ready to take treatment time for multiple myeloma patients down from hours to just minutes with its new formulation of blockbuster Darzalex, and the drug’s latest FDA approval couldn’t come at a more opportune time for
read moreDays after U.S. officials reported the first positive controlled data for Gilead’s remdesivir in COVID-19, the FDA has given the drug an emergency use authorization. More: Gilead's remdesivir scores emergency FDA nod in COVID-19 days after big data reveal Source:
read moreAbbVie may be working through COVID-19, but it’s pressing ahead with its Allergan merger, too—and taking stock of products hit by pandemic lockdowns. That puts Allergan’s aesthetics business top of mind, but AbbVie CEO Rick Gonzalez figures customers are ready and able
read moreGilead Sciences scored a massive win earlier this week with its first positive data readout for investigational candidate remdesivir in treating patients with severe COVID-19. Gilead already has its own supply of the drug humming in anticipation of high demand,
read moreAt the J.P. Morgan Healthcare Conference in January—back when few could predict the looming destruction of COVID-19—Amgen CEO Bob Bradway vowed the company would find new ways to make its $13.4 billion acquisition of Celgene’s psoriasis drug Otezla worth the
read more© 1994 - 2026 B.M. Pharmaceuticals